652 related articles for article (PubMed ID: 19695408)
1. Estimated annual direct expenditures in the United States as a result of inappropriate hypertension treatment according to national treatment guidelines.
Balu S
Clin Ther; 2009 Jul; 31(7):1581-94. PubMed ID: 19695408
[TBL] [Abstract][Full Text] [Related]
2. Incremental expenditure of treating hypertension in the United States.
Balu S; Thomas J
Am J Hypertens; 2006 Aug; 19(8):810-6; discussion 817. PubMed ID: 16876679
[TBL] [Abstract][Full Text] [Related]
3. Incremental direct expenditure of treating asthma in the United States.
Kamble S; Bharmal M
J Asthma; 2009 Feb; 46(1):73-80. PubMed ID: 19191142
[TBL] [Abstract][Full Text] [Related]
4. Incremental treatment expenditure of diabetes in the United States.
Balu S
Manag Care Interface; 2007 Apr; 20(4):20-7. PubMed ID: 17474327
[TBL] [Abstract][Full Text] [Related]
5. Economics of suboptimal drug use: cost-savings of using JNC-recommended medications for management of uncomplicated essential hypertension.
Xu KT; Moloney M; Phillips S
Am J Manag Care; 2003 Aug; 9(8):529-36. PubMed ID: 12921230
[TBL] [Abstract][Full Text] [Related]
6. Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and Nutrition Examination Survey 1999-2004.
Gu Q; Burt VL; Paulose-Ram R; Dillon CF
Am J Hypertens; 2008 Jul; 21(7):789-98. PubMed ID: 18451806
[TBL] [Abstract][Full Text] [Related]
7. Estimates and patterns of direct health care expenditures among individuals with back pain in the United States.
Luo X; Pietrobon R; Sun SX; Liu GG; Hey L
Spine (Phila Pa 1976); 2004 Jan; 29(1):79-86. PubMed ID: 14699281
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.
Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK
Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145
[TBL] [Abstract][Full Text] [Related]
9. Trends in health care expenditures, utilization, and health status among US adults with spine problems, 1997-2006.
Martin BI; Turner JA; Mirza SK; Lee MJ; Comstock BA; Deyo RA
Spine (Phila Pa 1976); 2009 Sep; 34(19):2077-84. PubMed ID: 19675510
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.
Loosbrock DL; Zhao Z; Johnstone BM; Morris LS
J Ment Health Policy Econ; 2003 Jun; 6(2):67-75. PubMed ID: 14578539
[TBL] [Abstract][Full Text] [Related]
11. Physician adherence to the national asthma prescribing guidelines: evidence from national outpatient survey data in the United States.
Navaratnam P; Jayawant SS; Pedersen CA; Balkrishnan R
Ann Allergy Asthma Immunol; 2008 Mar; 100(3):216-21. PubMed ID: 18426140
[TBL] [Abstract][Full Text] [Related]
12. Inappropriate antibiotic prescribing in managed care subjects with influenza.
Misurski DA; Lipson DA; Changolkar AK
Am J Manag Care; 2011 Sep; 17(9):601-8. PubMed ID: 21902445
[TBL] [Abstract][Full Text] [Related]
13. Medical care expenditures and earnings losses of persons with arthritis and other rheumatic conditions in the United States in 1997: total and incremental estimates.
Yelin E; Cisternas MG; Pasta DJ; Trupin L; Murphy L; Helmick CG
Arthritis Rheum; 2004 Jul; 50(7):2317-26. PubMed ID: 15248233
[TBL] [Abstract][Full Text] [Related]
14. Physician and patient factors associated with the prescribing of medications for sleep difficulties that are associated with high abuse potential or are expensive: an analysis of data from the National Ambulatory Medical Care Survey for 1996-2001.
Rasu RS; Shenolikar RA; Nahata MC; Balkrishnan R
Clin Ther; 2005 Dec; 27(12):1970-9. PubMed ID: 16507384
[TBL] [Abstract][Full Text] [Related]
15. Gender disparities in medical expenditures attributable to hypertension in the United States.
Basu R; Franzini L; Krueger PM; Lairson DR
Womens Health Issues; 2010; 20(2):114-25. PubMed ID: 20211429
[TBL] [Abstract][Full Text] [Related]
16. The economic impact of the introduction of home blood pressure measurement for the diagnosis and treatment of hypertension.
Funahashi J; Ohkubo T; Fukunaga H; Kikuya M; Takada N; Asayama K; Metoki H; Obara T; Inoue R; Hashimoto J; Totsune K; Kobayashi M; Imai Y
Blood Press Monit; 2006 Oct; 11(5):257-67. PubMed ID: 16932035
[TBL] [Abstract][Full Text] [Related]
17. The cost of obesity in Canada.
Birmingham CL; Muller JL; Palepu A; Spinelli JJ; Anis AH
CMAJ; 1999 Feb; 160(4):483-8. PubMed ID: 10081464
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of severe arterial hypertension: cost of drug prescriptions in accordance with ANAES guidelines].
Fender P; Guilhot J; Tilly B; Salanave B; Allemand H
Therapie; 2001; 56(2):111-8. PubMed ID: 11471361
[TBL] [Abstract][Full Text] [Related]
19. The medical cost of cardiometabolic risk factor clusters in the United States.
Sullivan PW; Ghushchyan V; Wyatt HR; Hill JO
Obesity (Silver Spring); 2007 Dec; 15(12):3150-8. PubMed ID: 18198326
[TBL] [Abstract][Full Text] [Related]
20. Costs of illness: United States, 1980.
Parsons PE; Lichtenstein R; Berki SE; Murt HA; Lepkowski JM; Stehouwer SA; Landis JR
Natl Med Care Util Expend Surv C; 1986 Apr; (3):1-90. PubMed ID: 10313412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
